Treatment Trials

5 Clinical Trials for Various Conditions

Focus your search

COMPLETED
Dextenza for Post-operative Treatment of Pterygium
Description

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery

COMPLETED
RMP-A03 Ocular Suspension in Patients With Pterygium
Description

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Conditions
COMPLETED
Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium
Description

Stage 1: Single Ascending Dose, Safety, Tolerability and Pharmacokinetics (n=24) Stage 2: Multiple Dose, Safety and Efficacy Study with 28-day Dosing and 5 months Followup (n=51)

Conditions
COMPLETED
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
Description

To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

Conditions
COMPLETED
Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
Description

This study will evaluate the safety and efficacy of Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) in patients with primary pterygium (abnormal growth on surface of eye).

Conditions